All Stories

  1. Heart in Distress: How Different Shock States Converge on Cardiac Dysfunction

    Article • Biomedicines, September 2026, MDPI AG

    Evangelos Oikonomou

  2. Metabolic Dysfunction-Associated Steatotic Liver Disease and Atrial Fibrillation Recurrence After Catheter Ablation: A Systematic Review and Meta-Analysis

    Article • Reviews in Cardiovascular Medicine, September 2026, IMR Press

    Evangelos Oikonomou

  3. Targeting Stress and the Gut–Brain Axis: Effects of Lifestyle and Psychobiotic Interventions on the Gut Microbiome in Adults—A Systematic Review of Randomized Controlled Trials

    Article • Nutrients, September 2026, MDPI AG

    Evangelos Oikonomou

  4. Global prevalence and clinical implications of coronary artery dominance: A meta-analysis

    Article • Hellenic Journal of Cardiology, September 2026, Elsevier

    Evangelos Oikonomou

  5. Microplastics in Human Thoracic Tissues: Increased Burden in Patients with Lung Malignancy

    Article • Journal of Clinical Medicine, August 2026, MDPI AG

    Evangelos Oikonomou

  6. Prevalence of Persistent Left Superior Vena Cava in Patients with Congenital Heart Disease: A Systematic Review with Meta-Analysis

    Article • Life, August 2026, MDPI AG

    Juan Sanchis-Gimeno, Evangelos Oikonomou

  7. Evaluation of Longitudinal CD40 and CD40L Changes During Adjuvant Breast Cancer Therapy and Their Association with Left Ventricular Dysfunction

    Article • Cancers, July 2026, MDPI AG

    Evangelos Oikonomou

  8. Incidence of Atrial Fibrillation Post Patent Foramen Ovale (PFO) Closure: A Meta-analysis

    Article • Current Cardiology Reviews, July 2026, Bentham Science Publishers

    Evangelos Oikonomou

  9. Burnout and Insomnia Among Greek Physicians Affiliated with the Athens Medical Association After the Acute Phase of the COVID-19 Pandemic: Prevalence and Contributing Factors

    Article • Epidemiologia, May 2026, MDPI AG

    Evangelos Oikonomou

  10. Artificial Intelligence for Prediction and Detection of Atrial Fibrillation from Sinus-Rhythm Electrocardiograms and Ambulatory Monitoring

    Article • Biomedicines, May 2026, MDPI AG

    Panteleimon Pantelidis, Evangelos Oikonomou

  11. The Effects of GLP-1 Receptor Agonists on Retinal Microvascular Alterations

    Article • Biomedicines, May 2026, MDPI AG

    Evangelos Oikonomou

  12. Left Main Revascularization in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis

    Article • Current Cardiology Reviews, May 2026, Bentham Science Publishers

    Evangelos Oikonomou

  13. Circulating miR-10b-5p as a Candidate Biomarker of Atrial Fibrillation Recurrence After Catheter Ablation: A Two-Phase Translational Study

    Article • EP Europace, April 2026, Oxford University Press (OUP)

    Evangelos Oikonomou

  14. When the Apex Deceives: A Mobile Left Ventricular Mass After Myocardial Infarction

    Article • Reports — Medical Cases Images and Videos, April 2026, MDPI AG

    Evangelos Oikonomou

  15. Changes in NT-proBNP Levels According to SGLT2 Inhibitor Use in Patients Hospitalized for Acute Heart Failure Decompensation: A Prospective Cohort Study

    Article • Life, April 2026, MDPI AG

    Evangelos Oikonomou

  16. Prevalence and clinical significance of coronary arteries variations: A systematic review with meta-analysis

    Article • Hellenic Journal of Cardiology, April 2026, Elsevier

    Evangelos Oikonomou

  17. Uric Acid, Homocysteine, and comorbidities in sarcoidosis

    Article • European Journal of Internal Medicine, April 2026, Elsevier

    Evangelos Oikonomou

  18. Cardiac Syncope: An Underestimated Cause of Unexplained Syncope in the Elderly-Data from a Single High-Volume Syncope Unit

    Article • Journal of Clinical Medicine, March 2026, MDPI AG

    Evangelos Oikonomou

  19. Proprotein Convertase Subtilisin/Kexin Type 9 and Atherosclerotic Plaque Progression: A Systematic Review and Meta-Analysis of Intravascular Imaging Studies

    Article • Reviews in Cardiovascular Medicine, March 2026, IMR Press

    Evangelos Oikonomou

  20. Artificial intelligence-enabled electrocardiography to predict impending episodes of ventricular tachycardia in individuals under continuous heart rhythm monitoring

    Article • Cochrane Database of Systematic Reviews, March 2026, Wiley

    Ioanna Miliou, Panteleimon Pantelidis, Evangelos Oikonomou

  21. Eligibility for biological treatments in COPD patients experiencing a severe COPD exacerbation

    Article • Respiratory Medicine, March 2026, Elsevier

    Evangelos Oikonomou

  22. Single Versus Double Perclose Vascular Closure Device in Transfemoral Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-Analysis

    Article • Angiology, February 2026, SAGE Publications

    Panteleimon Pantelidis, Evangelos Oikonomou

  23. Correction: Anastasiou et al. MicroRNA Signatures and Machine Learning Models for Predicting Cardiotoxicity in HER2-Positive Breast Cancer Patients. Pharmaceuticals 2025, 18, 1908

    Article • Pharmaceuticals, February 2026, MDPI AG

    Evangelos Oikonomou

  24. Unmasking Early Cardiac Fibrosis in Sarcoidosis: The Role of Plasma Aldosterone and Cardiac MRI

    Article • Journal of Clinical Medicine, January 2026, MDPI AG

    Evangelos Oikonomou

  25. Metformin Beyond Glycemic Control: Cardiovascular Protection and Diabetes Prevention

    Article • Journal of Cardiovascular Development and Disease, January 2026, MDPI AG

    Evangelos Oikonomou

  26. MicroRNA Signatures and Machine Learning Models for Predicting Cardiotoxicity in HER2-Positive Breast Cancer Patients

    Article • Pharmaceuticals, December 2025, MDPI AG

    Evangelos Oikonomou

  27. One Enzyme, Many Faces: The Expanding Role of DPP3 in Cardiovascular and Critical Care

    Article • Journal of Clinical Medicine, October 2025, MDPI AG

    Evangelos Oikonomou

  28. Prognostic Impact of Obesity, Cardiometabolic Risk Factors, and Vascular Function Markers on Outcomes in Ischemic Cardiomyopathy

    Article • Journal of Clinical Medicine, October 2025, MDPI AG

    Evangelos Oikonomou

  29. The Role of miRNAs in Chemotherapy-Induced Cardiotoxicity

    Article • Biomedicines, September 2025, MDPI AG

    Evangelos Oikonomou

  30. Artificial intelligence-enabled electrocardiographic ‘sex discrepancy’ as a predictor of atrial fibrillation recurrence: contextualising the findings of Park et al

    Article • European Heart Journal - Digital Health, September 2025, Oxford University Press (OUP)

    Panteleimon Pantelidis, Evangelos Oikonomou

  31. Trends in Utilization of Guideline-Directed Cardiorenal Protective Therapies for Chronic Kidney Disease in Patients with Cardiovascular Morbidity: Real World Data from Two Cross-Sectional Snapshots (HECMOS I and II)

    Article • Biomedicines, August 2025, MDPI AG

    Evangelos Oikonomou

  32. The Role of NLRP3 Inflammasome in Type 2 Diabetes Mellitus and Its Macrovascular Complications

    Article • Journal of Clinical Medicine, June 2025, MDPI AG

    Evangelos Oikonomou

  33. Lipoprotein (a) in the Development and Progression of Diabetic Retinopathy: A Systematic Review and Meta-Analysis

    Article • Medicina, June 2025, MDPI AG

    Evangelos Oikonomou

  34. Real-World Efficacy and Safety of the Subcutaneous Implantable Cardioverter Defibrillator: Insights from the GASP Registry

    Article • Biomedicines, June 2025, MDPI AG

    Evangelos Oikonomou

  35. Hybrid Pulmonary Rehabilitation Improves Cardiorespiratory Exercise Fitness in Formerly Hospitalised Long COVID Patients

    Article • Journal of Clinical Medicine, June 2025, MDPI AG

    Evangelos Oikonomou

  36. Endothelial Function and Matrix Metalloproteinase 9 (MMP9) in Women with Polycystic Ovary Syndrome (PCOS)

    Article • International Journal of Molecular Sciences, June 2025, MDPI AG

    Evangelos Oikonomou

  37. Mitochondrial Dysfunction in the Development and Progression of Cardiometabolic Diseases: A Narrative Review

    Article • Journal of Clinical Medicine, May 2025, MDPI AG

    Evangelos Oikonomou

  38. Endothelial Function and Pro-Inflammatory Cytokines as Prognostic Markers in Acute Coronary Syndromes

    Article • Diagnostics, April 2025, MDPI AG

    Evangelos Oikonomou

  39. A Tale of Two Diseases: Decoding Aortic Stenosis and Cardiac Amyloidosis

    Article • Journal of Clinical Medicine, April 2025, MDPI AG

    Panteleimon Pantelidis, Evangelos Oikonomou

  40. Gut Microbiota in Heart Failure—The Role of Inflammation

    Article • Biomedicines, April 2025, MDPI AG

    Evangelos Oikonomou, Dr. Petros N Fountoulakis

  41. Baseline right ventricular-to-pulmonary artery coupling and outcomes after transcatheter aortic valve replacement: a systematic review and meta-analysis

    Article • Hellenic Journal of Cardiology, April 2025, Elsevier

    Evangelos Oikonomou

  42. The Impact of the COVID-19 Pandemic on Medical Training at the Greek National Health Service: A Cross-Sectional Study

    Article • Epidemiologia, March 2025, MDPI AG

    Evangelos Oikonomou

  43. Linking Cardiovascular Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): The Role of Cardiometabolic Drugs in MASLD Treatment

    Article • Biomolecules, February 2025, MDPI AG

    Evangelos Oikonomou

  44. Unraveling Metabolic Dysfunction-Associated Steatotic Liver Disease Through the Use of Omics Technologies

    Article • International Journal of Molecular Sciences, February 2025, MDPI AG

    Evangelos Oikonomou

  45. Septic Cardiomyopathy: Difficult Definition, Challenging Diagnosis, Unclear Treatment

    Article • Journal of Clinical Medicine, February 2025, MDPI AG

    Evangelos Oikonomou

  46. FGF21 Analogues in Patients With Metabolic Diseases: Systematic Review and Meta‐Analysis of Randomised Controlled Trials

    Article • Liver International, February 2025, Wiley

    Evangelos Oikonomou

  47. Unraveling MASLD Through the Use of Omics Technologies

    Article • January 2025, MDPI AG

    Evangelos Oikonomou

  48. The Effect of Cardiometabolic Drugs on Non-Alcoholic Fatty Liver Disease (NAFLD), Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD), and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

    Article • December 2024, MDPI AG

    Evangelos Oikonomou

  49. Endothelial Glycocalyx Damage and Arterial Thickness in Patients with Retinal Vein Occlusion (RVO)

    Article • Journal of Clinical Medicine, December 2024, MDPI AG

    Evangelos Oikonomou

  50. MicroRNAs as Prognostic Biomarkers for Atrial Fibrillation Recurrence After Catheter Ablation: Current Evidence and Future Directions

    Article • Biomedicines, December 2024, MDPI AG

    Evangelos Oikonomou

  51. Cancer Therapy-Related Cardiac Dysfunction: A Review of Current Trends in Epidemiology, Diagnosis, and Treatment

    Article • Biomedicines, December 2024, MDPI AG

    Evangelos Oikonomou

  52. Navigating Heart–Lung Interactions in Mechanical Ventilation: Pathophysiology, Diagnosis, and Advanced Management Strategies in Acute Respiratory Distress Syndrome and Beyond

    Article • Journal of Clinical Medicine, December 2024, MDPI AG

    Evangelos Oikonomou

  53. Tailored Therapies for Cardiogenic Shock in Hypertrophic Cardiomyopathy: Navigating Emerging Strategies

    Article • Journal of Cardiovascular Development and Disease, December 2024, MDPI AG

    Panteleimon Pantelidis, Evangelos Oikonomou

  54. Dulaglutide and Dapagliflozin Combination Concurrently Improves the Endothelial Glycocalyx and Vascular and Myocardial Function in Patients with T2DM and Albuminuria vs. DPP-4i

    Article • Journal of Clinical Medicine, December 2024, MDPI AG

    Evangelos Oikonomou

  55. Response to “Letter to Editor From Ishaq MU et al: ‘Semaglutide Concurrently Improves Vascular and Liver Indices in Patients With Type 2 Diabetes and Fatty Liver Disease’”

    Article • Journal of the Endocrine Society, November 2024, Endocrine Society

    Evangelos Oikonomou

  56. Wearable Activity Trackers and Physical Activity Levels Among Members of the Athens Medical Association in Greece

    Article • Journal of Cardiovascular Development and Disease, October 2024, MDPI AG

    Evangelos Oikonomou

  57. Multifaceted Impact of SGLT2 Inhibitors in Heart Failure Patients: Exploring Diverse Mechanisms of Action

    Article • Biomedicines, October 2024, MDPI AG

    Evangelos Oikonomou

  58. The Cardiometabolic Risk in Women with Polycystic Ovarian Syndrome (PCOS): From Pathophysiology to Diagnosis and Treatment

    Article • Medicina, October 2024, MDPI AG

    Evangelos Oikonomou

  59. Influenza Vaccination Practices and Perceptions Among Young Athletes: A Cross-Sectional Study in Greece

    Article • Vaccines, August 2024, MDPI AG

    Evangelos Oikonomou

  60. Exercise Intolerance Is Associated with Cardiovascular Dysfunction in Long COVID-19 Syndrome

    Article • Journal of Clinical Medicine, July 2024, MDPI AG

    Evangelos Oikonomou

  61. Bridge to Life: Current Landscape of Temporary Mechanical Circulatory Support in Heart-Failure-Related Cardiogenic Shock

    Article • Journal of Clinical Medicine, July 2024, MDPI AG

    Evangelos Oikonomou

  62. The Association of Systemic Endothelial Dysfunction With Diffuse Diabetic Macular Edema

    Article • Angiology, June 2024, SAGE Publications

    Evangelos Oikonomou

  63. The Impact of the COVID-19 Pandemic on Elite Swimmers and Water Polo Players: Lessons for the Future

    Article • Epidemiologia, June 2024, MDPI AG

    Evangelos Oikonomou

  64. Impairment in Right Ventricular-Pulmonary Arterial Coupling in Overweight and Obesity

    Article • Journal of Clinical Medicine, June 2024, MDPI AG

    Evangelos Oikonomou

  65. Coronary Plaque Erosion: Epidemiology, Diagnosis, and Treatment

    Article • International Journal of Molecular Sciences, May 2024, MDPI AG

    Evangelos Oikonomou

  66. Young and older patients with acute myocardial infarction: differences in risk factors and angiographic characteristics

    Article • Hellenic Journal of Cardiology, May 2024, Elsevier

    Evangelos Oikonomou

  67. MicroRNAs in Atrial Fibrillation: Mechanisms, Vascular Implications, and Therapeutic Potential

    Article • Biomedicines, April 2024, MDPI AG

    Evangelos Oikonomou

  68. Unveiling the Role of Endothelial Dysfunction: A Possible Key to Enhancing Catheter Ablation Success in Atrial Fibrillation

    Article • International Journal of Molecular Sciences, February 2024, MDPI AG

    Panteleimon Pantelidis, Evangelos Oikonomou

  69. Silent Myocardial Ischemia: From Pathophysiology to Diagnosis and Treatment

    Article • Biomedicines, January 2024, MDPI AG

    Evangelos Oikonomou

  70. The Role of Ranolazine in Heart Failure-Current Concepts

    Article • The American Journal of Cardiology, December 2023, Elsevier

    Evangelos Oikonomou

  71. Diabetes Mellitus in Acute Coronary Syndrome

    Article • Life, November 2023, MDPI AG

    Evangelos Oikonomou

  72. New-Onset Atrial Fibrillation in the Critically Ill COVID-19 Patients Hospitalized in the Intensive Care Unit

    Article • Journal of Clinical Medicine, November 2023, MDPI AG

    Evangelos Oikonomou

  73. Impact of drinking water hardness on carotid atherosclerosis and arterial stiffness: Insights from the “Corinthia” study

    Article • Hellenic Journal of Cardiology, November 2023, Elsevier

    Evangelos Oikonomou, Professor Nikolaos S. Thomaidis

  74. Novel Biomarkers and Their Role in the Diagnosis and Prognosis of Acute Coronary Syndrome

    Article • Life, September 2023, MDPI AG

    Evangelos Oikonomou

  75. Non-Alcoholic Fatty Liver Disease and Echocardiographic Parameters of Left Ventricular Diastolic Function: A Systematic Review and Meta-Analysis

    Article • International Journal of Molecular Sciences, September 2023, MDPI AG

    Panteleimon Pantelidis, Evangelos Oikonomou

  76. Attitudes and Practices Related to COVID-19 Vaccination with the Second Booster Dose among Members of Athens Medical Association: Results from a Cross-Sectional Study

    Article • Vaccines, September 2023, MDPI AG

    Evangelos Oikonomou

  77. Novel Approaches to the Management of Diabetes Mellitus in Patients with Coronary Artery Disease

    Article • Current Pharmaceutical Design, September 2023, Bentham Science Publishers

    Evangelos Oikonomou

  78. Inflammasomes in Atherosclerosis—From Pathophysiology to Treatment

    Article • Pharmaceuticals, August 2023, MDPI AG

    Evangelos Oikonomou

  79. Metabolic Syndrome and Atrial Fibrillation: Different Entities or Combined Disorders

    Article • Journal of Personalized Medicine, August 2023, MDPI AG

    Evangelos Oikonomou

  80. Exercise Effects on Left Ventricular Remodeling in Patients with Cardiometabolic Risk Factors

    Article • Life, August 2023, MDPI AG

    Evangelos Oikonomou

  81. Diffuse LAD and LV Thrombus as Possible Manifestation of Protein-S Deficiency in a Young Patient

    Article • JACC Case Reports, August 2023, Elsevier

    Evangelos Oikonomou

  82. Novel Anti-Inflammatory Therapies in Coronary Artery Disease and Acute Coronary Syndromes

    Article • Life, July 2023, MDPI AG

    Evangelos Oikonomou

  83. The Role of Right Ventriculo–Arterial Coupling in Symptoms Presentation of Patients with Hypertrophic Cardiomyopathy

    Article • Journal of Clinical Medicine, July 2023, MDPI AG

    Evangelos Oikonomou

  84. Correlation of Clinical Outcomes with the Prominent Indication of Transcatheter Paravalvular Leak Closure: A Multicenter Experience

    Article • Journal of Clinical Medicine, June 2023, MDPI AG

    Evangelos Oikonomou

  85. Exercise Effects on Left Ventricular Remodeling in Patients With Cardiometabolic Risk Factors

    Article • June 2023, MDPI AG

    Evangelos Oikonomou

  86. The Role of Right Ventriculo-Arterial Coupling in Symptoms Presentation of Patients With Hypertrophic Cardiomyopathy

    Article • June 2023, MDPI AG

    Evangelos Oikonomou

  87. Midterm Outcomes in Patients With Aortic Stenosis Treated With Contemporary Balloon‐Expandable and Self‐Expanding Valves: Does Valve Size Have an Impact on Outcome?

    Article • Journal of the American Heart Association, June 2023, Wolters Kluwer Health

    Evangelos Oikonomou

  88. The Role of Macrophages in Atherosclerosis: Pathophysiologic Mechanisms and Treatment Considerations

    Article • International Journal of Molecular Sciences, May 2023, MDPI AG

    Evangelos Oikonomou

  89. Lipoprotein(a) and calcific aortic valve disease initiation and progression: a systematic review and meta-analysis

    Article • Cardiovascular Research, April 2023, Oxford University Press (OUP)

    Panteleimon Pantelidis, Evangelos Oikonomou

  90. The Role of Rehabilitation in Arterial Function Properties of Convalescent COVID-19 Patients

    Article • Journal of Clinical Medicine, March 2023, MDPI AG

    Evangelos Oikonomou

  91. Impact of Evolution of Self-Expandable Aortic Valve Design: Peri-Operative and Short-Term Outcomes

    Article • Journal of Clinical Medicine, February 2023, MDPI AG

    Panteleimon Pantelidis, Evangelos Oikonomou

  92. Molecular Mechanisms and Therapeutic Implications of Endothelial Dysfunction in Patients with Heart Failure

    Article • International Journal of Molecular Sciences, February 2023, MDPI AG

    Evangelos Oikonomou

  93. Lipoprotein(a) in Atherosclerotic Diseases: From Pathophysiology to Diagnosis and Treatment

    Article • Molecules, January 2023, MDPI AG

    Panteleimon Pantelidis, Evangelos Oikonomou

  94. Lipoprotein (a) levels and Abdominal Aortic Aneurysm. A Systematic Review and Meta-analysis

    Article • Current Pharmaceutical Design, November 2022, Bentham Science Publishers

    Panteleimon Pantelidis, Evangelos Oikonomou

  95. The Anti-Inflammatory Effect of Novel Antidiabetic Agents

    Article • Life, November 2022, MDPI AG

    Evangelos Oikonomou

  96. Interleukin-1 in Coronary Artery Disease

    Article • Current Topics in Medicinal Chemistry, November 2022, Bentham Science Publishers

    Evangelos Oikonomou, Panteleimon Pantelidis

  97. Vaccination Against SARS-CoV-2 Protects from COVID-19-induced Endothelial Dysfunction

    Article • Current Pharmaceutical Design, November 2022, Bentham Science Publishers

    Evangelos Oikonomou

  98. Evaluation of the Perceptions, Attitudes and Practices among Greek Non-Professional Athletes Visiting a Public Hospital during March 2022, towards COVID-19 Vaccination and Its Consequences on Sports Training and Sports Activity

    Article • Vaccines, October 2022, MDPI AG

    Evangelos Oikonomou

  99. The effect of stress management in patients post-acute myocardial infarction

    Article • Hellenic Journal of Cardiology, October 2022, Elsevier

    Evangelos Oikonomou

  100. Impaired left ventricular deformation and ventricular-arterial coupling in post-COVID-19: association with autonomic dysregulation

    Article • Heart and Vessels, September 2022, Springer Science + Business Media

    Evangelos Oikonomou, Panteleimon Pantelidis

  101. COVID-19, Endothelium and the Cardiometabolic Patient: A Possible Role for Capillary Leak Syndrome

    Article • Biomedicines, September 2022, MDPI AG

    Evangelos Oikonomou

  102. Granulocyte Colony-Stimulating Factor Ameliorates Endothelial Activation and Thrombotic Diathesis Biomarkers in a Murine Model of Hind Limb Ischemia

    Article • Biomedicines, September 2022, MDPI AG

    Evangelos Oikonomou

  103. Percutaneous Treatment Approaches in Atrial Fibrillation: Current Landscape and Future Perspectives

    Article • Biomedicines, September 2022, MDPI AG

    Evangelos Oikonomou

  104. Pericoronary fat attenuation index—a new imaging biomarker and its diagnostic and prognostic utility: a systematic review and meta-analysis

    Article • European Heart Journal - Cardiovascular Imaging, September 2022, Oxford University Press (OUP)

    Evangelos Oikonomou

  105. Association of Growth Differentiation Factor 15 with Arterial Stiffness and Endothelial Function in Subpopulations of Patients with Coronary Artery Disease: A Proof-of-Concept Study

    Article • Recent Advances in Inflammation & Allergy Drug Discovery, September 2022, Bentham Science Publishers

    Evangelos Oikonomou

  106. Non-Invasive Modalities in the Assessment of Vulnerable Coronary Atherosclerotic Plaques

    Article • Tomography, July 2022, MDPI AG

    Evangelos Oikonomou

  107. The Role of Endothelial Related Circulating Biomarkers in COVID-19. A Systematic Review and Meta-analysis

    Article • Current Medicinal Chemistry, June 2022, Bentham Science Publishers

    Panteleimon Pantelidis, Evangelos Oikonomou

  108. The Role of Cell-derived Microparticles in Cardiovascular Diseases: Current Concepts

    Article • Current Pharmaceutical Design, June 2022, Bentham Science Publishers

    Evangelos Oikonomou

  109. Increased Influenza Vaccination Coverage among Members of the Athens Medical Association Amidst COVID-19 Pandemic

    Article • Vaccines, May 2022, MDPI AG

    Evangelos Oikonomou

  110. Expression of Tissue microRNAs in Ascending Aortic Aneurysms and Dissections

    Article • Angiology, May 2022, SAGE Publications

    Panteleimon Pantelidis, Evangelos Oikonomou

  111. Evaluation of Knowledge, Attitudes and Practices Related to Self-Testing Procedure against COVID-19 among Greek Students: A Pilot Study

    Article • International Journal of Environmental Research and Public Health, April 2022, MDPI AG

    Evangelos Oikonomou

  112. Factors Associated with Platelet Activation-Recent Pharmaceutical Approaches

    Article • International Journal of Molecular Sciences, March 2022, MDPI AG

    Evangelos Oikonomou

  113. The association of diabetes mellitus with carotid atherosclerosis and arterial stiffness in the Corinthia study

    Article • Nutrition Metabolism and Cardiovascular Diseases, March 2022, Elsevier

    Evangelos Oikonomou

  114. The Association of Physical Activity with Arterial Stiffness and Inflammation: Insight from the “Corinthia” Study

    Article • Angiology, February 2022, SAGE Publications

    Evangelos Oikonomou

  115. A case report of left ventricular thrombus formation following aggressive decongestion treatment

    Article • European Heart Journal - Case Reports, February 2022, Oxford University Press (OUP)

    Evangelos Oikonomou

  116. Genetic Predisposition and Inflammatory Inhibitors in COVID-19: Where Do We Stand?

    Article • Biomedicines, January 2022, MDPI AG

    Evangelos Oikonomou

  117. Association of arterial stiffness with functional parameters in patients with systolic heart failure: Data from the Corinthia study

    Article • Hellenic Journal of Cardiology, January 2022, Elsevier

    Evangelos Oikonomou

  118. Atrial Fibrillation: Pathogenesis, Predisposing Factors, and Genetics

    Article • International Journal of Molecular Sciences, December 2021, MDPI AG

    Evangelos Oikonomou

  119. Inflammation in Coronary Microvascular Dysfunction

    Article • International Journal of Molecular Sciences, December 2021, MDPI AG

    Evangelos Oikonomou

  120. MicroRNAs as Biomarkers in Hypertrophic Cardiomyopathy: Current State of the Art

    Article • Current Medicinal Chemistry, November 2021, Bentham Science Publishers

    Alexios Antonopoulos, Evangelos Oikonomou

  121. Inflammatory Mediators of Platelet Activation: Focus on Atherosclerosis and COVID-19

    Article • International Journal of Molecular Sciences, October 2021, MDPI AG

    Evangelos Oikonomou

  122. Sex Differences in Clinical Outcomes of Patients with Stable Coronary Artery Disease after Percutaneous Coronary Intervention

    Article • Current Pharmaceutical Design, September 2021, Bentham Science Publishers

    Evangelos Oikonomou

  123. MicroRNAs in the Management of Heart Failure

    Article • Current Medicinal Chemistry, August 2021, Bentham Science Publishers

    Evangelos Oikonomou, Aimilios Kalampogias

  124. Risk factors profile of young and older patients with myocardial infarction

    Article • Cardiovascular Research, August 2021, Oxford University Press (OUP)

    Evangelos Oikonomou

  125. Inflammatory Mechanisms Contributing to Endothelial Dysfunction

    Article • Biomedicines, July 2021, MDPI AG

    Evangelos Oikonomou

  126. Inflammatory Mechanisms in COVID-19 and Atherosclerosis: Current Pharmaceutical Perspectives

    Article • International Journal of Molecular Sciences, June 2021, MDPI AG

    Evangelos Oikonomou

  127. The Hellenic Journal of Cardiology: a 64-year voyage of discovery from the cradle of European civilization to the world

    Article • European Heart Journal, June 2021, Oxford University Press (OUP)

    Evangelos Oikonomou

  128. Regulation of Long Non-Coding RNAs by Statins in Atherosclerosis

    Article • Biomolecules, April 2021, MDPI AG

    Evangelos Oikonomou

  129. The Effect of DPP-4i on Endothelial Function and Arterial Stiffness in Patients with Type 2 Diabetes: A Systematic Review of Randomized Placebo-controlled Trials

    Article • Current Pharmaceutical Design, December 2020, Bentham Science Publishers

    Evangelos Oikonomou, MD, PhD ANDROMACHI VRYONIDOU - BOMPOTA, Professor NIKOLAOS TENTOLOURIS, Alexios Antonopoulos

  130. Novel Antidiabetic Agents: Cardiovascular and Safety Outcomes

    Article • Current Pharmaceutical Design, December 2020, Bentham Science Publishers

    Evangelos Oikonomou, Alexios Antonopoulos

  131. Association of Soluble Suppression of Tumorigenesis-2 (ST2) with Endothelial Function in Patients with Ischemic Heart Failure

    Article • International Journal of Molecular Sciences, December 2020, MDPI AG

    Evangelos Oikonomou

  132. Pro-inflammatory Cytokines in Acute Coronary Syndromes

    Article • Current Pharmaceutical Design, October 2020, Bentham Science Publishers

    Evangelos Oikonomou, Alexios Antonopoulos, Dr. Petros N Fountoulakis

  133. Arterial stiffness and microvascular disease in type 2 diabetes

    Article • European Journal of Clinical Investigation, August 2020, Wiley

    Evangelos Oikonomou

  134. “The role of intracoronary administration of stem cells on myocardial reperfusion injury”

    Article • Hellenic Journal of Cardiology, August 2020, Elsevier

    Evangelos Oikonomou

  135. Hospital attendance and admission trends for cardiac diseases during the COVID-19 outbreak and lockdown in Greece

    Article • Public Health, August 2020, Elsevier

    Evangelos Oikonomou

  136. High-Intensity Endurance and Strength Training in Water Polo Olympic Team Players: Impact on Arterial Wall Properties

    Article • Cardiology, July 2020, Karger Publishers

    Evangelos Oikonomou, Dr. Petros N Fountoulakis

  137. Antithrombotic Treatment in Diabetes Mellitus: A Review of the Literature about Antiplatelet and Anticoagulation Strategies Used for Diabetic Patients in Primary and Secondary Prevention

    Article • Current Pharmaceutical Design, July 2020, Bentham Science Publishers

    Evangelos Oikonomou, VASILIKI CHARA MYSTAKIDI

  138. Antithrombotic Therapy in Carotid Artery Disease

    Article • Current Pharmaceutical Design, July 2020, Bentham Science Publishers

    Evangelos Oikonomou, Alexios Antonopoulos, VASILIKI CHARA MYSTAKIDI

  139. Current Antithrombotic Therapy: Beyond Coronary Artery Disease

    Article • Current Pharmaceutical Design, July 2020, Bentham Science Publishers

    Evangelos Oikonomou

  140. Proposed algorithm for return to sports in competitive athletes who have suffered COVID-19

    Article • Hellenic Journal of Cardiology, July 2020, Elsevier

    Evangelos Oikonomou

  141. Development of a risk score for early saphenous vein graft failure: An individual patient data meta-analysis

    Article • Journal of Thoracic and Cardiovascular Surgery, July 2020, Elsevier

    Evangelos Oikonomou

  142. A reappraisal of the role of transthoracic ultrasound in the era of COVID-19. Patient evaluation through new windows

    Article • Hellenic Journal of Cardiology, June 2020, Elsevier

    Evangelos Oikonomou

  143. Relationship between whole grain consumption and arterial stiffness. Results of the Corinthia cross-sectional study

    Article • Hellenic Journal of Cardiology, June 2020, Elsevier

    Evangelos Oikonomou

  144. Acute Coronary Syndrome with Non-ruptured Plaques (NONRUPLA): Novel Ideas and Perspectives

    Article • Current Atherosclerosis Reports, May 2020, Springer Science + Business Media

    Evangelos Oikonomou

  145. Cardiovascular disease and socioeconomic status

    Article • European Heart Journal, May 2020, Oxford University Press (OUP)

    Evangelos Oikonomou

  146. Alirocumab and evolocumab: an indirect comparison of cardiovascular benefits

    Article • European Heart Journal - Cardiovascular Pharmacotherapy, May 2020, Oxford University Press (OUP)

    Evangelos Oikonomou

  147. Endothelial dysfunction and impaired arterial wall properties in patients with retinal vein occlusion

    Article • Vascular Medicine, April 2020, SAGE Publications

    Evangelos Oikonomou

  148. MicroRNAs in Cardiovascular Disease

    Article • Hellenic Journal of Cardiology, April 2020, Elsevier

    Evangelos Oikonomou

  149. The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design

    Article • Hellenic Journal of Cardiology, April 2020, Elsevier

    Evangelos Oikonomou, Dr Dimitrios A Vrachatis

  150. Coronary Artery Disease and Endothelial Dysfunction: Novel Diagnostic and Therapeutic Approaches

    Article • Current Medicinal Chemistry, March 2020, Bentham Science Publishers

    Evangelos Oikonomou, Michael Spartalis, Professor Athanasios G. Papavassiliou, Angeliki Papastavrou, Maria Paraskevi Panoilia

  151. Mir-335-5p as a Potential Regulator of LRP1 Expression in Abdominal Aortic Aneurysm

    Article • Hellenic Journal of Cardiology, February 2020, Elsevier

    Evangelos Oikonomou

  152. Acute exposure to diesel affects inflammation and vascular function

    Article • European Journal of Preventive Cardiology, January 2020, SAGE Publications

    Evangelos Oikonomou, Dr. Petros N Fountoulakis

  153. Aortic regurgitation in competitive athletes: The role of multimodality imaging for clinical decision-making

    Article • European Journal of Preventive Cardiology, December 2019, SAGE Publications

    Alexios Antonopoulos, Evangelos Oikonomou

  154. Diagnostic performance of electrocardiographic criteria in echocardiographic diagnosis of different patterns of left ventricular hypertrophy

    Article • Annals of Noninvasive Electrocardiology, November 2019, Wiley

    Evangelos Oikonomou, Dr. Petros N Fountoulakis

  155. The aetiology of death for marathon runner Phidippides?

    Article • European Heart Journal, August 2019, Oxford University Press (OUP)

    Evangelos Oikonomou

  156. Reply: Possible Effect of Alcohol Consumption on Aortic Dilatation by Inducing the Renin–Angiotensin–Aldosterone System

    Article • Angiology, July 2019, SAGE Publications

    Evangelos Oikonomou

  157. Aortic stiffening is associated with increased left ventricular mass in women but not in men

    Article • European Journal of Preventive Cardiology, July 2019, SAGE Publications

    Evangelos Oikonomou

  158. Breakfast association with arterial stiffness and carotid atherosclerotic burden. Insights from the ‘Corinthia’ study

    Article • Nutrition Metabolism and Cardiovascular Diseases, July 2019, Elsevier

    Evangelos Oikonomou

  159. Galectin-3 and Arterial Stiffness in Patients with Heart Failure: A Pilot Study

    Article • Current Vascular Pharmacology, June 2019, Bentham Science Publishers

    Evangelos Oikonomou, Dimitrios Karlis

  160. The influence of resting heart rate on pulse wave velocity measurement is mediated by blood pressure and depends on aortic stiffness levels: insights from the Corinthia study

    Article • Physiological Measurement, June 2019, Institute of Physics Publishing

    Evangelos Oikonomou

  161. Pseudoexfoliative Glaucoma, Endothelial Dysfunction, and Arterial Stiffness

    Article • Journal of Glaucoma, June 2019, Wolters Kluwer Health

    Evangelos Oikonomou

  162. Alcohol Consumption and Aortic Root Dilatation: Insights from the Corinthia Study

    Article • Angiology, May 2019, SAGE Publications

    Evangelos Oikonomou

  163. Arterial stiffness and subclinical aortic damage of reclassified subjects as stage 1 hypertension according to the new 2017 ACC/AHA blood pressure guidelines

    Article • VASA, May 2019, Hogrefe Publishing Group

    Evangelos Oikonomou

  164. Atrial Fibrillation: Biomarkers Determining Prognosis

    Article • Current Medicinal Chemistry, April 2019, Bentham Science Publishers

    Evangelos Oikonomou

  165. Biomarkers Determining Prognosis of Atrial Fibrillation Ablation

    Article • Current Medicinal Chemistry, April 2019, Bentham Science Publishers

    Evangelos Oikonomou

  166. Biomarkers in Atrial Fibrillation and Heart Failure

    Article • Current Medicinal Chemistry, April 2019, Bentham Science Publishers

    Evangelos Oikonomou

  167. MicroRNAs in Atrial Fibrillation

    Article • Current Medicinal Chemistry, April 2019, Bentham Science Publishers

    Evangelos Oikonomou

  168. Galectin-3

    Article • Journal of the American College of Cardiology, April 2019, Elsevier

    Evangelos Oikonomou

  169. Cardiovascular effects of electronic cigarettes: A systematic review and meta-analysis

    Article • European Journal of Preventive Cardiology, March 2019, SAGE Publications

    Evangelos Oikonomou

  170. The effect of diet, lifestyle and psychological factors in the prognosis of ischemic heart failure

    Article • March 2019, Elsevier

    Evangelos Oikonomou

  171. Hyponatremia in patients with atrial fibrillation and heart failure: The difficult triangle

    Article • Hellenic Journal of Cardiology, March 2019, Elsevier

    Evangelos Oikonomou

  172. Vitamin D: A cardiovascular risk biomarker or a treatment target?

    Article • Hellenic Journal of Cardiology, March 2019, Elsevier

    Evangelos Oikonomou

  173. Cancer Therapeutics-Related Cardiovascular Complications. Mechanisms, Diagnosis and Treatment

    Article • Current Pharmaceutical Design, February 2019, Bentham Science Publishers

    Evangelos Oikonomou, Dr Konstantinos Toutouzas

  174. Heart failure a cluster of comorbidities or a unique entity?

    Article • International Journal of Cardiology, February 2019, Elsevier

    Evangelos Oikonomou

  175. Associations between Adiponectin Gene Variability, Proinflammatory and Angiogenetic Markers: Implications for Microvascular Disease Development in Type 2 Diabetes Mellitus?

    Article • Current Vascular Pharmacology, January 2019, Bentham Science Publishers

    Alexios Antonopoulos, Evangelos Oikonomou, Angeliki Papapanagiotou, Eva Kassi, Professor Athanasios G. Papavassiliou

  176. The impact of sedentary behavior patterns on carotid atherosclerotic burden: Implications from the Corinthia epidemiological study

    Article • Atherosclerosis, January 2019, Elsevier

    Evangelos Oikonomou

  177. The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives

    Article • European Cardiology Review, January 2019, Medical Media Communications, Ltd. T/A Radcliffe Cardiology

    Evangelos Oikonomou

  178. Effects of Newer Antidiabetic Drugs on Endothelial Function and Arterial Stiffness: A Systematic Review and Meta-Analysis

    Article • Journal of Diabetes Research, December 2018, Hindawi Publishing Corporation

    Evangelos Oikonomou, Alexios Antonopoulos, Dr MARINA NOUTSOU, VASILIKI CHARA MYSTAKIDI

  179. The association among biomarkers of renal and heart function in patients with heart failure: the role of NGAL

    Article • Biomarkers in Medicine, December 2018, Future Medicine

    Evangelos Oikonomou

  180. Coronary Microcirculation and the No-reflow Phenomenon

    Article • Current Pharmaceutical Design, November 2018, Bentham Science Publishers

    Evangelos Oikonomou

  181. Myocardial performance versus exercise tolerance. What matters the most in patients with heart failure?

    Article • Hellenic Journal of Cardiology, November 2018, Elsevier

    Evangelos Oikonomou

  182. The Impact of Omega 3 Fatty Acids in Atherosclerosis and Arterial Stiffness: An Overview of their Actions

    Article • Current Pharmaceutical Design, September 2018, Bentham Science Publishers

    Evangelos Oikonomou, Nikolaos Papageorgiou, Professor Athanasios G. Papavassiliou

  183. Polymorphism Gln27Glu of β2 Adrenergic Receptors in Patients with Ischaemic Cardiomyopath

    Article • Current Vascular Pharmacology, September 2018, Bentham Science Publishers

    Constantinos Missouris, Evangelos Oikonomou, Sofia Metaxa, Peter Drakakis

  184. Inflammation: A pathogenetic mechanism or a mediator, linking risk factors and cardiovascular disease?

    Article • International Journal of Cardiology, August 2018, Elsevier

    Evangelos Oikonomou

  185. Non-natriuretic peptide biomarkers in heart failure with preserved and reduced ejection fraction

    Article • Biomarkers in Medicine, June 2018, Future Medicine

    Evangelos Oikonomou

  186. Effects of omega-3 polyunsaturated fatty acids on fibrosis, endothelial function and myocardial performance, in ischemic heart failure patients

    Article • Clinical Nutrition, May 2018, Elsevier

    Evangelos Oikonomou

  187. Circulating microparticles: Simply a research tool or a candidate clinical meaningful biomarker?

    Article • International Journal of Cardiology, May 2018, Elsevier

    Evangelos Oikonomou

  188. Local Low Shear Stress and Endothelial Dysfunction in Patients With Nonobstructive Coronary Atherosclerosis

    Article • Journal of the American College of Cardiology, May 2018, Elsevier

    Evangelos Oikonomou

  189. Impact of “high” implantation on functionality of self-expandable bioprosthesis during the short- and long-term outcome of patients who undergo transcatheter aortic valve implantation: Is high implantation beneficial?

    Article • Cardiovascular Therapeutics, April 2018, Wiley

    Evangelos Oikonomou

  190. Anti-inflammatory agents in peripheral arterial disease

    Article • Current Opinion in Pharmacology, April 2018, Elsevier

    Evangelos Oikonomou

  191. Coronary versus carotid artery plaques. Similarities and differences regarding biomarkers morphology and prognosis

    Article • Current Opinion in Pharmacology, April 2018, Elsevier

    Evangelos Oikonomou

  192. Editorial overview: Cardiovascular and renal: Novel therapies in peripheral artery disease

    Article • Current Opinion in Pharmacology, April 2018, Elsevier

    Evangelos Oikonomou

  193. Peripheral artery disease: a micro-RNA-related condition?

    Article • Current Opinion in Pharmacology, April 2018, Elsevier

    Evangelos Oikonomou

  194. Predictors of switching from nonsteroidal anti-inflammatory drugs to corticosteroids in patients with acute pericarditis and impact on clinical outcome

    Article • Hellenic Journal of Cardiology, April 2018, Elsevier

    Evangelos Oikonomou

  195. Interrelationship between diabetes mellitus and heart failure: the role of peroxisome proliferator-activated receptors in left ventricle performance

    Article • Heart Failure Reviews, February 2018, Springer Science + Business Media

    Evangelos Oikonomou

  196. Echocardiography for the management of patients with biventricular pacing: Possible roles in cardiac resynchronization therapy implementation

    Article • Hellenic Journal of Cardiology, February 2018, Elsevier

    Professor Antonis S Manolis, Evangelos Oikonomou

  197. Statins and Contrast-Induced Nephropathy: A Systematic Review and Meta-Analysis

    Article • Current Pharmaceutical Design, February 2018, Bentham Science Publishers

    Evangelos Oikonomou

  198. Statins in Aortic Disease

    Article • Current Pharmaceutical Design, February 2018, Bentham Science Publishers

    Evangelos Oikonomou

  199. Prognostic significance of arterial stiffness and osteoprotegerin in patients with stable coronary artery disease

    Article • European Journal of Clinical Investigation, January 2018, Wiley

    Professor Athanasios G. Papavassiliou, Evangelos Oikonomou

  200. 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomographic Imaging Detects Aortic Wall Inflammation in Patients With Repaired Coarctation of Aorta

    Article • Circulation Cardiovascular Imaging, January 2018, Wolters Kluwer Health

    Evangelos Oikonomou

  201. Flow-Mediated Dilation of Brachial Artery as a Screening Tool for Anthracycline-Induced Cardiotoxicity

    Article • Journal of the American College of Cardiology, December 2017, Elsevier

    Evangelos Oikonomou

  202. Statins and inflammation in cardiovascular disease

    Article • Current Pharmaceutical Design, October 2017, Bentham Science Publishers

    Evangelos Oikonomou

  203. Statins and left ventricular function

    Article • Current Pharmaceutical Design, September 2017, Bentham Science Publishers

    Evangelos Oikonomou, Dr. Petros N Fountoulakis

  204. Statins in Stable Angina Pectoris

    Article • Current Pharmaceutical Design, August 2017, Bentham Science Publishers

    Nikolaos Papageorgiou, Evangelos Oikonomou

  205. Statins in Aortic Stenosis

    Article • Current Pharmaceutical Design, August 2017, Bentham Science Publishers

    Evangelos Oikonomou

  206. Long-term endothelial dysfunction after trans-radial catheterization: A meta-analytic approach

    Article • Journal of Cardiac Surgery, August 2017, Wiley

    Alexios Antonopoulos, Konstantinos Aznaouridis, Evangelos Oikonomou

  207. Western Dietary Pattern Is Associated With Severe Coronary Artery Disease

    Article • Angiology, July 2017, SAGE Publications

    Evangelos Oikonomou, Alexios Antonopoulos

  208. Redox State in Atrial Fibrillation Pathogenesis and Relevant Therapeutic Approaches

    Article • Current Medicinal Chemistry, July 2017, Bentham Science Publishers

    Alexios Antonopoulos, Evangelos Oikonomou

  209. Macrovascular function indices for the prediction of diabetic retinopathy development in patients with type 2 diabetes

    Article • European Journal of Preventive Cardiology, June 2017, SAGE Publications

    Alexios Antonopoulos, Evangelos Oikonomou

  210. Antiplatelet and Anticoagulation Therapy in Structural Heart Disease Interventions Beyond TAVI

    Article • Current Pharmaceutical Design, April 2017, Bentham Science Publishers

    Dr Dimitrios A Vrachatis, Evangelos Oikonomou

  211. Genetics in the Clinical Decision of Antiplatelet Treatment

    Article • Current Pharmaceutical Design, April 2017, Bentham Science Publishers

    Dr Dimitrios A Vrachatis, Evangelos Oikonomou

  212. Beneficial Effects of Sildenafil on Tissue Perfusion and Inflammation in a Murine Model of Limb Ischemia and Atherosclerosis

    Article • Current Vascular Pharmacology, April 2017, Bentham Science Publishers

    Evangelos Oikonomou

  213. Impact of balloon aortic valvuloplasty on transcatheter aortic valve implantation with self-expandable valve

    Article • Journal of Cardiology, January 2017, Elsevier

    Dr Dimitrios A Vrachatis, Maria Kariori, Evangelos Oikonomou

  214. Genotyping, Platelet Activation, and Cardiovascular Outcome in Patients after Percutaneous Coronary Intervention: Two Pieces of the Puzzle of Clopidogrel Resistance

    Article • Cardiology, January 2017, Karger Publishers

    Evangelos Oikonomou

  215. Prognostic implications of epicardial fat volume quantification in acute pericarditis

    Article • European Journal of Clinical Investigation, December 2016, Wiley

    Alexios Antonopoulos, Evangelos Oikonomou

  216. Established and novel treatment options in acute myocarditis, with or without heart failure

    Article • Expert Review of Cardiovascular Therapy, November 2016, Taylor & Francis

    Evangelos Oikonomou

  217. Correlation of CoreValve implantation ‘true cover index’ with short and mid-term aortic regurgitation: A novel index

    Article • International Journal of Cardiology, November 2016, Elsevier

    Dr Dimitrios A Vrachatis, Evangelos Oikonomou

  218. The impact of T786C and G894T polymorphisms of eNOS on vascular endothelial growth factor serum levels in type 2 diabetes patients

    Article • International Journal of Cardiology, November 2016, Elsevier

    Alexios Antonopoulos, Evangelos Oikonomou

  219. Effects of transradial coronary catheterization on systemic and local vascular endothelial function and inflammatory process

    Article • International Journal of Cardiology, November 2016, Elsevier

    Alexios Antonopoulos, Evangelos Oikonomou

  220. Usefulness of C-Reactive Protein as a Predictor of Contrast-Induced Nephropathy After Percutaneous Coronary Interventions in Patients With Acute Myocardial Infarction and Presentation of a New Risk Score (Athens CIN Score)

    Article • The American Journal of Cardiology, November 2016, Elsevier

    Alexios Antonopoulos, Evangelos Oikonomou

  221. Novel risk factors’ hunting. Lessons from the study of older olds

    Article • Hellenic Journal of Cardiology, November 2016, Elsevier

    Evangelos Oikonomou

  222. The effect of in-hospital acquired thrombocytopenia on the outcome of patients with acute coronary syndromes: A systematic review and meta-analysis

    Article • Thrombosis Research, November 2016, Elsevier

    Evangelos Oikonomou

  223. The prognostic role of C-reactive protein after myocardial infarction in patients with normal or mildly impaired left ventricle systolic function

    Article • International Journal of Cardiology, October 2016, Elsevier

    Evangelos Oikonomou

  224. Dual or Single Antiplatelet Therapy After Transcatheter Aortic Valve Implantation? A Systematic Review and Meta-Analysis

    Article • Current Pharmaceutical Design, September 2016, Bentham Science Publishers

    Dr Dimitrios A Vrachatis, Evangelos Oikonomou

  225. Targeting percutaneous cardiovascular interventions at all who will benefit the most: The reality of the Eastern European countries

    Article • International Journal of Cardiology, August 2016, Elsevier

    Evangelos Oikonomou

  226. The impact of dietary flavonoid supplementation on smoking-induced inflammatory process and fibrinolytic impairment

    Article • Atherosclerosis, August 2016, Elsevier

    Evangelos Oikonomou

  227. Duration of Dual Antiplatelet Therapy after Coronary Stenting

    Article • Current Pharmaceutical Design, July 2016, Bentham Science Publishers

    Evangelos Oikonomou

  228. Acute effects of different types of aerobic exercise on endothelial function and arterial stiffness

    Article • European Journal of Preventive Cardiology, July 2016, SAGE Publications

    Evangelos Oikonomou

  229. Characterization of vascular phenotype in patients with coronary artery ectasia: The role of endothelial dysfunction

    Article • International Journal of Cardiology, July 2016, Elsevier

    Alexios Antonopoulos, Evangelos Oikonomou

  230. The Interaction Between Gender and Diabetes Mellitus in the Coronary Heart Disease Risk

    Article • Current Pharmaceutical Design, June 2016, Bentham Science Publishers

    Evangelos Oikonomou

  231. Antiplatelet Therapy in Acute Coronary Syndromes. Evidence Based Medicine

    Article • Current Pharmaceutical Design, June 2016, Bentham Science Publishers

    Evangelos Oikonomou

  232. Incessant pericarditis following dual-chamber cardioverter defibrillation device implantation

    Article • International Journal of Cardiology, June 2016, Elsevier

    Evangelos Oikonomou

  233. Environment and cardiovascular disease: rationale of the Corinthia study

    Article • Hellenic Journal of Cardiology, May 2016, Elsevier

    Evangelos Oikonomou

  234. Do we really need novel echocardiographic modalities to confirm the superiority of the intact His-Purkinje conduction system over pacing modes?

    Article • Hellenic Journal of Cardiology, May 2016, Elsevier

    Evangelos Oikonomou

  235. Impact of C34T P2Y12 ADP receptor polymorphism and smoking status on cardiovascular outcome in coronary artery disease patients receiving clopidogrel

    Article • International Journal of Cardiology, May 2016, Elsevier

    Evangelos Oikonomou

  236. Impairment of arterial elastic properties and elevated circulating levels of transforming growth factor-beta in subjects with repaired coarctation of aorta

    Article • International Journal of Cardiology, March 2016, Elsevier

    Alexios Antonopoulos, Evangelos Oikonomou

  237. Basic Mechanisms in Atherosclerosis: The Role of Calcium

    Article • Medicinal Chemistry, February 2016, Bentham Science Publishers

    Evangelos Oikonomou

  238. Inflammatory cytokines in atherosclerosis: current therapeutic approaches

    Article • European Heart Journal, February 2016, European Society of Cardiology

    Evangelos Oikonomou

  239. The Acute Impact of Different Types of Aerobic Exercise on Arterial Wave Reflections and Inflammation

    Article • Cardiology, January 2016, Karger Publishers

    Miss Stavroula Tsitkanou, Evangelos Oikonomou

  240. Atherogenesis and hyperlipidemia a not straightforward association: We really need a novel biomarker?

    Article • International Journal of Cardiology, January 2016, Elsevier

    Evangelos Oikonomou

  241. Different Prognostic Significance of Cardiac Troponin at Presentation and Peak Cardiac Troponin in Patients with Non-ST Segment Elevation Myocardial Infarction

    Article • Cardiology, January 2016, Karger Publishers

    Evangelos Oikonomou

  242. Impact of Laparoscopic Sleeve Gastrectomy on Weight Loss and Associated Comorbidities in Adolescents and Young Adults

    Article • Journal of Laparoendoscopic & Advanced Surgical Techniques, December 2015, Mary Ann Liebert Inc

    Evangelos Oikonomou

  243. Real-time three-dimensional echocardiography: never before clinical efficacy looked so picturesque

    Article • International Journal of Cardiology, November 2015, Elsevier

    Evangelos Oikonomou

  244. Clopidogrel response variability is associated with endothelial dysfunction in coronary artery disease patients receiving dual antiplatelet therapy

    Article • Atherosclerosis, September 2015, Elsevier

    Evangelos Oikonomou

  245. Arterial Wall Elastic Properties and Endothelial Dysfunction in the Diabetic Foot Syndrome in Patients With Type 2 Diabetes

    Article • Diabetes Care, August 2015, American Diabetes Association

    Alexios Antonopoulos, Evangelos Oikonomou

  246. The role of microRNAs in coronary artery disease: From pathophysiology to diagnosis and treatment

    Article • Atherosclerosis, August 2015, Elsevier

    Evangelos Oikonomou

  247. Vascular function and ocular involvement in sarcoidosis

    Article • Microvascular Research, July 2015, Elsevier

    Evangelos Oikonomou

  248. Genetic testing and antiplatelet treatment: Still way to go?

    Article • International Journal of Cardiology, May 2015, Elsevier

    Evangelos Oikonomou

  249. Atorvastatin treatment improves endothelial function through endothelial progenitor cells mobilization in ischemic heart failure patients

    Article • Atherosclerosis, February 2015, Elsevier

    Evangelos Oikonomou

  250. Flow-mediated dilation: Is it just a research tool or a useful biomarker for cardiovascular prognosis

    Article • International Journal of Cardiology, February 2015, Elsevier

    Evangelos Oikonomou

  251. An unusual case of a three coronary artery spasm

    Article • International Journal of Cardiology, January 2015, Elsevier

    Evangelos Oikonomou

  252. Role of Endothelial Dysfunction and Arterial Stiffness in the Development of Diabetic Retinopathy: Figure 1

    Article • Diabetes Care, December 2014, American Diabetes Association

    Evangelos Oikonomou

  253. Reply: Long term impact of CPAP on myocardial function in OSA. Always measurable cardiac index?

    Article • Sleep And Breathing, December 2014, Springer Science + Business Media

    Evangelos Oikonomou

  254. Endothelial dysfunction in conduit arteries and in microcirculation. Novel therapeutic approaches

    Article • Pharmacology & Therapeutics, December 2014, Elsevier

    Evangelos Oikonomou

  255. Impact of C34T P2Y12 genotype on endothelial function and arterial stiffness in patients after percutaneous coronary intervention receiving clopidogrel

    Article • International Journal of Cardiology, December 2014, Elsevier

    Evangelos Oikonomou

  256. Impact of folic acid administration in homocysteine levels, inflammation and in atherosclerotic plaque area in apoE deficient mice

    Article • International Journal of Cardiology, December 2014, Elsevier

    Evangelos Oikonomou

  257. Oxidative Stress and Early Atherosclerosis: Novel Antioxidant Treatment

    Article • Cardiovascular Drugs and Therapy, November 2014, Springer Science + Business Media

    Evangelos Oikonomou

  258. High platelet reactivity is associated with vascular function in patients after percutaneous coronary intervention receiving clopidogrel

    Article • International Journal of Cardiology, November 2014, Elsevier

    Evangelos Oikonomou

  259. Segmental myocardial hypokinesis and hypertrophy as initial echocardiographic presentation of myocarditis

    Article • International Journal of Cardiology, October 2014, Elsevier

    Evangelos Oikonomou

  260. Combined effects of smoking and interleukin-6 and C-reactive protein genetic variants on endothelial function, inflammation, thrombosis and incidence of coronary artery disease

    Article • International Journal of Cardiology, September 2014, Elsevier

    Evangelos Oikonomou

  261. Vascular effects of circulating CD4-T cells in patients with unstable angina

    Article • International Journal of Cardiology, September 2014, Elsevier

    Evangelos Oikonomou

  262. Pro-Inflammatory Interleukin Genotypes Potentiate Early and Advanced Atherosclerosis Differently

    Article • Journal of the American College of Cardiology, August 2014, Elsevier

    Evangelos Oikonomou

  263. Impact of continuous positive airway pressure treatment on myocardial performance in patients with obstructive sleep apnea. A conventional and tissue Doppler echocardiographic study

    Article • Sleep And Breathing, July 2014, Springer Science + Business Media

    Evangelos Oikonomou

  264. Cystatin-C serum levels and vascular function in heart failure

    Article • International Journal of Cardiology, May 2014, Elsevier

    Evangelos Oikonomou

  265. Divergent effects of folic acid administration on inflammatory status and cholesterol levels in apoE deficient mice

    Article • International Journal of Cardiology, May 2014, Elsevier

    Evangelos Oikonomou

  266. The Natural History of Multifocal Atrial Rhythms in Elderly Outpatients: Insights from the “Ikaria Study”

    Article • Annals of Noninvasive Electrocardiology, April 2014, Wiley

    Evangelos Oikonomou

  267. The impact of AMPD1 gene polymorphism on vascular function and inflammation in patients with coronary artery disease

    Article • International Journal of Cardiology, April 2014, Elsevier

    Evangelos Oikonomou

  268. Novel biomarkers in heart failure: usefulness in clinical practice

    Article • Expert Review of Cardiovascular Therapy, February 2014, Taylor & Francis

    Evangelos Oikonomou

  269. Omega-3 PUFAs improved endothelial function and arterial stiffness with a parallel antiinflammatory effect in adults with metabolic syndrome

    Article • Atherosclerosis, January 2014, Elsevier

    Evangelos Oikonomou

  270. Statins in heart failure—With preserved and reduced ejection fraction. An update

    Article • Pharmacology & Therapeutics, January 2014, Elsevier

    Evangelos Oikonomou

  271. Vitamin D serum levels are associated with cardiovascular outcome in coronary artery disease

    Article • International Journal of Cardiology, October 2013, Elsevier

    Evangelos Oikonomou

  272. Favorable Effects of Concord Grape Juice on Endothelial Function and Arterial Stiffness in Healthy Smokers

    Article • American Journal of Hypertension, September 2013, Oxford University Press (OUP)

    Evangelos Oikonomou

  273. Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease

    Article • International Journal of Cardiology, September 2013, Elsevier

    Evangelos Oikonomou

  274. The impact of CYP2C19 genotype on cardiovascular events and platelet reactivity in patients with coronary artery disease receiving clopidogrel

    Article • International Journal of Cardiology, September 2013, Elsevier

    Evangelos Oikonomou

  275. Long-Term Fish Intake Preserves Kidney Function in Elderly Individuals: The Ikaria Study

    Article • Journal of Renal Nutrition, July 2013, Elsevier

    Evangelos Oikonomou

  276. MicroRNAs: Novel Diagnostic and Prognostic Biomarkers in Atherosclerosis

    Article • Current Topics in Medicinal Chemistry, June 2013, Bentham Science Publishers

    Evangelos Oikonomou

  277. Novel Biomarkers Assessing Endothelial Dysfunction: Role of microRNAs

    Article • Current Topics in Medicinal Chemistry, June 2013, Bentham Science Publishers

    Evangelos Oikonomou

  278. MicroRNAs: Biomarkers for Cardiovascular Disease in Patients with Diabetes Mellitus

    Article • Current Topics in Medicinal Chemistry, June 2013, Bentham Science Publishers

    Evangelos Oikonomou

  279. Diagnostic and Therapeutic Potentials of microRNAs in Heart Failure

    Article • Current Topics in Medicinal Chemistry, June 2013, Bentham Science Publishers

    Evangelos Oikonomou

  280. MicroRNAs in the Diagnosis and Treatment of Unstable Angina

    Article • Current Topics in Medicinal Chemistry, June 2013, Bentham Science Publishers

    Evangelos Oikonomou

  281. MicroRNAs in Cardiovascular Therapeutics

    Article • Current Topics in Medicinal Chemistry, June 2013, Bentham Science Publishers

    Evangelos Oikonomou

  282. Effects of omega-3 fatty acids on endothelial function, arterial wall properties, inflammatory and fibrinolytic status in smokers: A cross over study

    Article • International Journal of Cardiology, June 2013, Elsevier

    Evangelos Oikonomou

  283. Flavonoids in Atherosclerosis: An Overview of Their Mechanisms of Action

    Article • Current Medicinal Chemistry, May 2013, Bentham Science Publishers

    Evangelos Oikonomou

  284. Dose-dependent effects of short term atorvastatin treatment on arterial wall properties and on indices of left ventricular remodeling in ischemic heart failure

    Article • Atherosclerosis, April 2013, Elsevier

    Evangelos Oikonomou

  285. Consumption of a boiled Greek type of coffee is associated with improved endothelial function: The Ikaria Study

    Article • Vascular Medicine, March 2013, SAGE Publications

    Evangelos Oikonomou

  286. Genetic Predisposition to Left Ventricular Hypertrophy and the Potential Involvement of Cystatin-C in Untreated Hypertension

    Article • American Journal of Hypertension, March 2013, Oxford University Press (OUP)

    Evangelos Oikonomou

  287. Aortic elastic properties and cognitive function in elderly individuals: The Ikaria Study

    Article • Maturitas, March 2013, Elsevier

    Evangelos Oikonomou

  288. Low Total Testosterone Levels are Associated With the Metabolic Syndrome in Elderly Men: The Role of Body Weight, Lipids, Insulin Resistance, and Inflammation; The Ikaria Study

    Article • The Review of Diabetic Studies, January 2013, Society for Biomedical Diabetes Research (SBDR)

    Evangelos Oikonomou

  289. Aortic artery distensibility shows inverse correlation with heart rate variability in elderly non-hypertensive, cardiovascular disease-free individuals: the Ikaria Study

    Article • Heart and Vessels, July 2012, Springer Science + Business Media

    Evangelos Oikonomou

  290. Comparable effects of pioglitazone and perindopril on circulating endothelial progenitor cells, inflammatory process and oxidative stress in patients with diabetes mellitus

    Article • International Journal of Cardiology, June 2012, Elsevier

    Evangelos Oikonomou

  291. Adiponectin and Cardiovascular Disease: Mechanisms and New Therapeutic Approaches

    Article • Current Medicinal Chemistry, March 2012, Bentham Science Publishers

    Evangelos Oikonomou

  292. Genetic polymorphism M235T of angiotensinogen: Effects on endothelial function and arterial stiffness in hypertensives

    Article • International Journal of Cardiology, March 2012, Elsevier

    Evangelos Oikonomou

  293. Novel Biomarkers Assessing the Calcium Deposition in Coronary Artery Disease

    Article • Current Medicinal Chemistry, February 2012, Bentham Science Publishers

    Evangelos Oikonomou

  294. Asymmetric dimethylarginine (ADMA): Is really a biomarker for cardiovascular prognosis?

    Article • International Journal of Cardiology, December 2011, Elsevier

    Evangelos Oikonomou

  295. Cross-sectional relationship of a Mediterranean type diet to diastolic heart function in chronic heart failure patients

    Article • Heart and Vessels, September 2011, Springer Science + Business Media

    Evangelos Oikonomou

  296. Anti-tumor necrosis factor alpha treatment with adalimumab improves significantly endothelial function and decreases inflammatory process in patients with chronic psoriasis

    Article • International Journal of Cardiology, September 2011, Elsevier

    Evangelos Oikonomou

  297. Distinct role of electrocardiographic criteria in echocardiographic diagnosis of left ventricular hypertrophy according to age, in the general population

    Article • Journal of Hypertension, August 2011, Wolters Kluwer Health

    Evangelos Oikonomou

  298. Gender variation of exercise-induced anti-arrhythmic protection: the Ikaria Study

    Article • QJM, July 2011, Oxford University Press (OUP)

    Evangelos Oikonomou

  299. Association of Sarcoidosis With Endothelial Function, Arterial Wall Properties, and Biomarkers of Inflammation

    Article • American Journal of Hypertension, June 2011, Oxford University Press (OUP)

    Evangelos Oikonomou

  300. The association between glaucoma, vascular function and inflammatory process

    Article • International Journal of Cardiology, January 2011, Elsevier

    Evangelos Oikonomou